Vicinitas Therapeutics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 22

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $65M

  • Investors
  • 8

Vicinitas Therapeutics General Information

Description

Operator of a biotechnology company intended to develop differentiated disease therapies based on the targeted protein stabilization platform. The company's protein stabilization platform addresses protein instability and degradation, and haploinsufficiency diseases, by slowing the turnover rates of the remaining gene and protein, enabling healthcare professionals to develop novel therapeutics for cancer and genetic disorders.

Contact Information

Website
www.vicinitas.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 442 Littlefield Avenue
  • South San Francisco, CA 94080
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 442 Littlefield Avenue
  • South San Francisco, CA 94080
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vicinitas Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 28-Jul-2022 $65M Completed Startup
1. University Spin-Out 01-Jan-2022 Completed Startup
To view Vicinitas Therapeutics’s complete valuation and funding history, request access »

Vicinitas Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Vicinitas Therapeutics’s complete cap table history, request access »

Vicinitas Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to develop differentiated disease therapies based on the targeted protein s
Drug Discovery
South San Francisco, CA
22 As of 2023

Wilmington, DE
 

Vancouver, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Vicinitas Therapeutics Competitors (83)

One of Vicinitas Therapeutics’s 83 competitors is Ayala Pharmaceuticals, a Corporation company based in Wilmington, DE.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ayala Pharmaceuticals Corporation Wilmington, DE
viDA Therapeutics Venture Capital-Backed Vancouver, Canada
etherna Formerly VC-backed Niel, Belgium
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland
Intellia Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 5 of 83 competitors. Get the full list »

Vicinitas Therapeutics Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • Pending

  • Expiring in next 12 mo

Vicinitas Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024097355-A1 Deubiquitinase-targeting chimeras and related methods Inactive 02-Nov-2022

Vicinitas Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vicinitas Therapeutics Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Andreessen Horowitz Venture Capital Minority
Deerfield Management Venture Capital Minority
Droia Ventures Venture Capital Minority
GV Corporate Venture Capital Minority
Novartis Corporation Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

Vicinitas Therapeutics FAQs

  • When was Vicinitas Therapeutics founded?

    Vicinitas Therapeutics was founded in 2022.

  • Where is Vicinitas Therapeutics headquartered?

    Vicinitas Therapeutics is headquartered in South San Francisco, CA.

  • What is the size of Vicinitas Therapeutics?

    Vicinitas Therapeutics has 22 total employees.

  • What industry is Vicinitas Therapeutics in?

    Vicinitas Therapeutics’s primary industry is Drug Discovery.

  • Is Vicinitas Therapeutics a private or public company?

    Vicinitas Therapeutics is a Private company.

  • What is the current valuation of Vicinitas Therapeutics?

    The current valuation of Vicinitas Therapeutics is .

  • What is Vicinitas Therapeutics’s current revenue?

    The current revenue for Vicinitas Therapeutics is .

  • How much funding has Vicinitas Therapeutics raised over time?

    Vicinitas Therapeutics has raised $65M.

  • Who are Vicinitas Therapeutics’s investors?

    Andreessen Horowitz, Deerfield Management, Droia Ventures, GV, and Novartis are 5 of 8 investors who have invested in Vicinitas Therapeutics.

  • Who are Vicinitas Therapeutics’s competitors?

    Ayala Pharmaceuticals, viDA Therapeutics, etherna, CRISPR Therapeutics, and Intellia Therapeutics are some of the 83 competitors of Vicinitas Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process